Amgen (AMGN) Free Cash Flow (2009 - 2026)

Amgen (AMGN) has reported Free Cash Flow for 18 consecutive years, with $1.5 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Free Cash Flow rose 50.71% year-over-year to $1.5 billion; the TTM figure through Mar 2026 stood at $8.6 billion (down 21.24% YoY), while the FY2025 annual figure was $8.1 billion, down 22.07% from the prior year.
• Free Cash Flow came in at $1.5 billion for Q1 2026 at Amgen, up from $961.0 million in the prior quarter.
• The five-year high for Free Cash Flow was $4.4 billion in Q4 2024, with the low at $289.0 million in Q4 2023.
• Average Free Cash Flow over 5 years is $2.1 billion, with a median of $2.0 billion recorded in 2022.
• Across the five-year window, Free Cash Flow plunged 87.48% in 2023 and jumped 1422.49% in 2024, its largest moves.
• Year by year, Free Cash Flow stood at $2.3 billion in 2022, then slumped by 87.48% to $289.0 million in 2023, then surged by 1422.49% to $4.4 billion in 2024, then tumbled by 78.16% to $961.0 million in 2025, then soared by 53.69% to $1.5 billion in 2026.
• According to Business Quant data, Free Cash Flow over the past three periods registered $1.5 billion, $961.0 million, and $4.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.